Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Current Assets (2018 - 2026)

TELA Bio has reported Current Assets over the past 8 years, most recently at $75.6 million for Q4 2025.

  • For Q4 2025, Current Assets fell 3.19% year-over-year to $75.6 million; the TTM value through Dec 2025 reached $75.6 million, down 3.19%, while the annual FY2025 figure was $75.6 million, 3.19% down from the prior year.
  • Current Assets for Q4 2025 was $75.6 million at TELA Bio, up from $56.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $89.2 million in Q2 2023 and troughed at $44.1 million in Q3 2024.
  • A 5-year average of $64.9 million and a median of $64.1 million in 2021 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: soared 95.4% in 2023 and later tumbled 46.35% in 2024.
  • Year by year, Current Assets stood at $59.1 million in 2021, then grew by 5.74% to $62.4 million in 2022, then increased by 14.86% to $71.7 million in 2023, then rose by 8.85% to $78.1 million in 2024, then decreased by 3.19% to $75.6 million in 2025.
  • Business Quant data shows Current Assets for TELA at $75.6 million in Q4 2025, $56.0 million in Q3 2025, and $60.7 million in Q2 2025.